Welcome to WyomingLifeScience.com
WyomingLifeScience.com is part of a specialized network of state- and province-based biotechnology, medical device,
and life science sites that includes more than 4,500 biotechnology, medical device, pharmaceutical companies,
non-profit research institutions, universities and supporting service sector companies across the U.S. and Canada.
This network addresses the growing informational and service needs of companies, patients, educators and others in
their respective states while providing clients the opportunity to cost effectively
advertise their job openings, events, facility availability and other services at the state level,
regionally or nationwide. We welcome your comments, suggestions and requests for informational content and supporting
services.
 More...
Destination Wyoming
Are you considering a move to Wyoming? Relocating your business to
Wyoming? Starting a company? Or just interested in Wyoming?
This section will answer many of your questions regarding the life science industry in Wyoming, the province's
economy, tax structure and cost of living, education, transportation, climate, recreational opportunities, history,
industry resources, and more.
More...
|
|
|
Local News...
Free News Release Posting & Archiving Service
- Wyeth names Michael Kamarck President, Technical Operations & Product Supply Wyeth announced that Michael Kamarck, Ph.D., 57, has been promoted to President, Technical Operations & Product Supply (TO&PS). Dr. Kamarck will be responsible for all aspects of technical operations and product supply for Wyeth.
Wyeth November 20, 2008
- Wyeth declares preferred stock dividend At a meeting of the Board of Directors of Wyeth, a dividend of fifty cents ($0.50) per share on the outstanding shares of Preferred Stock was declared payable on January 2, 2009 to stockholders of record at the close of business on December 12, 2008.
Wyeth November 20, 2008
- Transgenomic awarded SBIR grant Transgenomic announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) award by the National Science Foundation (NSF) to support the development of its proposed SURVEYOR Endonuclease Adaptor-ligated Libraries (SEAL) technology.
Transgenomic November 20, 2008
- Tibotec begins enrollment in Europe for Phase III trial of telaprevir Tibotec BVBA announced that it has begun enrolling patients in its phase III study of telaprevir (VX-950), an investigational protease inhibitor (PI), in patients with chronic genotype 1 hepatitis C virus (HCV) for whom the current standard treatment has not been successful.
Johnson & Johnson November 20, 2008
- Tibotec presents interim findings for TMC435, an investigational genotype 1 HepC treatment New clinical data show antiviral activity of TMC435, an investigational protease inhibitor (PI) being developed by Tibotec BVBA for the treatment of chronic hepatitis C virus (HCV) infection.
Johnson & Johnson November 20, 2008
More... | Submit News Release | National News
|
New Job Postings...
Free Job Posting Trial Offer
More... |
Job Advertising...
| About Job Postings...
|
New Facilities Available...
ATC clean room constructors...validation guaranteed!
More... |
Facility Advertising...
|
Upcoming Events...
Free Event Posting Service
 More... |
Submit Event |
Event Advertising...
|
|
Learn About Wyoming's BioHistory
Why is there a biotechnology industry in Wyoming? Will the industry continue
to grow in Wyoming? What do other states have? Each state has a unique story
that explains why a given industry has developed in a specific region and not in others.
Through Wyoming BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industries in the state of Wyoming.
More...
BioEvolution Posters
More...
November is American Diabetes Month
Diabetes is a leading cause of kidney failure, blindness and amputations, and a major cause of heart
disease and stroke. Nearly 24 million Americans have diabetes, and about one quarter (or 5.7 million)
of them don't know that they have the disease. Millions more are at risk of developing diabetes.
Diabetes is a costly disease associated with serious complications and premature death. It is a major
cause of heart disease and stroke and a leading cause of leg and foot amputations unrelated to injury,
kidney failure, and new blindness in adults.
More...
BioFact
(1846) - Ether is first used as a surgical anesthetic at Massachusetts General Hospital in Boston.
It's a Small World
|
| |
Bacteria Culture
| |
Science Quote
"Scientific research is compounded of ... empirical procedures, general speculative ideas, and mathematical or abstract reasoning."
| - |
James Bryant Conant, U. S. Chemist and Educator
|
|
(1893-1978)
|
|
